Quick Answer
USANA HEALTH SCIENCES INC reported Cash and Equivalents of $158.38 million for fiscal year 2025.
USANA HEALTH SCIENCES INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $158.38M | -12.9% |
| 2024 | $181.77M | -45.0% |
| 2023 | $330.42M | +14.6% |
| 2022 | $288.42M | +20.3% |
| 2021 | $239.83M | -23.1% |
| 2020 | $311.92M | +32.8% |
| 2019 | $234.83M | +9.6% |
| 2018 | $214.33M | -13.3% |
| 2017 | $247.13M | +40.6% |
| 2016 | $175.77M | +22.7% |
| 2015 | $143.21M | +28.9% |
| 2014 | $111.13M | -19.1% |
| 2013 | $137.34M | +93.9% |
| 2012 | $70.84M | +40.7% |
| 2011 | $50.35M | +0.0% |
| 2010 | $50.35M | +268.7% |
| 2009 | $13.66M | +2.8% |
| 2008 | $13.28M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $145.35M | -60.2% | -4.0% |
| June 30, 2025 | $151.34M | -54.5% | -15.7% |
| March 31, 2025 | $179.61M | -45.3% | -1.2% |
| December 31, 2024 | $181.77M | -45.0% | -50.2% |
| September 30, 2024 | $364.89M | +18.8% | +9.8% |
| June 30, 2024 | $332.42M | +10.7% | +1.2% |
| March 31, 2024 | $328.34M | +11.1% | -0.6% |
| December 31, 2023 | $330.42M | +14.6% | +7.6% |
- USANA HEALTH SCIENCES INC showed a decrease of -12.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, USANA HEALTH SCIENCES INC’s cash and equivalents has grown by 1092.5% (from $13.28 million to $158.38 million).
- The most recent figure is from USANA HEALTH SCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: